By Mill Chart
Last update: Apr 29, 2025
For growth-minded investors, high revenue and EPS growth are key criteria. Today, we'll examine whether GENMAB A/S -SP ADR (NASDAQ:GMAB) fits the bill for growth investing, particularly as it forms a base and hints at a potential breakout. Remember, due diligence is essential, but GENMAB A/S -SP ADR has caught our attention on our screen for growth with base formation. It may warrant additional investigation.
To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. GMAB has achieved a 8 out of 10:
Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. GMAB has achieved a 8 out of 10:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. GMAB has earned a 7 out of 10:
ChartMill assigns a Setup Rating to every stock to determine the degree of consolidation. This rating, ranging from 0 to 10, is updated daily and evaluates various short-term technical indicators. GMAB currently holds a 7 as its setup rating, suggesting a particular level of consolidation in the stock.
Although the technical rating is bad, GMAB does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 20.64. Right above this resistance zone may be a good entry point. We notice that large players showed an interest for GMAB in the last couple of days, which is a good sign.
Our Strong Growth screener lists more Strong Growth stocks and is updated daily.
For an up to date full fundamental analysis you can check the fundamental report of GMAB
Our latest full technical report of GMAB contains the most current technical analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
20.63
+0.04 (+0.19%)
Find more stocks in the Stock Screener
Based on a technical and fundamental analysis of NASDAQ:GMAB we can say: GENMAB A/S -SP ADR (NASDAQ:GMAB), a strong growth stock, setting up for a breakout.
Peter Lynch, one of the most successful investors of all time, focused on growth stocks with strong fundamentals and a business model that’s easy to understand. Let’s analyze whether GENMAB A/S -SP ADR (NASDAQ:GMAB) fits his legendary investment approach.
GENMAB A/S -SP ADR was identified as a growth stock that isn't overvalued. NASDAQ:GMAB is excelling in various growth indicators while maintaining a solid financial footing.